Molina Healthcare, Inc. (NYSE:MOH) Stock Position Lowered by TCW Group Inc.

TCW Group Inc. lessened its position in Molina Healthcare, Inc. (NYSE:MOH) by 5.8% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 270,893 shares of the company’s stock after selling 16,780 shares during the period. TCW Group Inc.’s holdings in Molina Healthcare were worth $63,324,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Penserra Capital Management LLC raised its stake in shares of Molina Healthcare by 85.3% in the 4th quarter. Penserra Capital Management LLC now owns 126 shares of the company’s stock worth $26,000 after buying an additional 58 shares in the last quarter. Archer Investment Corp acquired a new stake in shares of Molina Healthcare during the fourth quarter worth $39,000. NEXT Financial Group Inc raised its position in shares of Molina Healthcare by 395.3% during the fourth quarter. NEXT Financial Group Inc now owns 213 shares of the company’s stock worth $45,000 after purchasing an additional 170 shares during the period. Alpha DNA Investment Management LLC acquired a new stake in shares of Molina Healthcare during the fourth quarter worth $54,000. Finally, CWM LLC raised its position in shares of Molina Healthcare by 236.9% during the first quarter. CWM LLC now owns 283 shares of the company’s stock worth $66,000 after purchasing an additional 199 shares during the period. 94.89% of the stock is currently owned by institutional investors.

In other Molina Healthcare news, insider Jeff D. Barlow sold 3,000 shares of the business’s stock in a transaction dated Thursday, May 13th. The stock was sold at an average price of $265.04, for a total value of $795,120.00. Following the completion of the sale, the insider now owns 77,162 shares of the company’s stock, valued at $20,451,016.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Garrey Carruthers sold 825 shares of the business’s stock in a transaction dated Monday, March 1st. The stock was sold at an average price of $222.50, for a total value of $183,562.50. The disclosure for this sale can be found here. Insiders sold 5,750 shares of company stock valued at $1,466,176 in the last ninety days. Insiders own 1.07% of the company’s stock.

Shares of NYSE MOH opened at $260.48 on Monday. The business’s 50-day moving average price is $248.42 and its two-hundred day moving average price is $223.70. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.96 and a quick ratio of 1.96. Molina Healthcare, Inc. has a one year low of $151.40 and a one year high of $273.01. The company has a market capitalization of $15.21 billion, a P/E ratio of 19.53, a price-to-earnings-growth ratio of 1.65 and a beta of 0.74.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, April 28th. The company reported $4.44 EPS for the quarter, beating analysts’ consensus estimates of $3.78 by $0.66. Molina Healthcare had a return on equity of 43.16% and a net margin of 4.37%. The firm had revenue of $6.52 billion for the quarter, compared to the consensus estimate of $6.08 billion. During the same quarter in the previous year, the company posted $2.92 earnings per share. The business’s quarterly revenue was up 43.4% compared to the same quarter last year. On average, equities analysts anticipate that Molina Healthcare, Inc. will post 12.81 EPS for the current year.

A number of brokerages have recently issued reports on MOH. Barclays reaffirmed an “overweight” rating and set a $260.00 target price on shares of Molina Healthcare in a research report on Thursday, February 25th. Truist lifted their price target on Molina Healthcare from $260.00 to $290.00 in a report on Wednesday, April 14th. Mizuho lifted their price target on Molina Healthcare from $245.00 to $273.00 and gave the company a “buy” rating in a report on Thursday, May 6th. The Goldman Sachs Group began coverage on Molina Healthcare in a report on Thursday, January 21st. They set a “neutral” rating and a $217.00 price target on the stock. Finally, Zacks Investment Research downgraded Molina Healthcare from a “hold” rating to a “sell” rating and set a $267.00 price target on the stock. in a report on Tuesday, April 20th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the company. The company has an average rating of “Buy” and an average target price of $248.23.

About Molina Healthcare

Molina Healthcare, Inc provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. The company operates in two segments, Health Plans and Other. As of December 31, 2020, it served approximately 4.0 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 15 states.

Featured Story: Trade Deficit

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.